Skip to contentD
Dare Bioscience, Inc.
D
DAREDare Bioscience, Inc. Q3 2016 · 10-Q
Revenue—
Net Income-$16.11K-$16.11KN/M vs Q3 2015 EPS Diluted-$0.02-$0.02N/M vs Q3 2015 Operating Cash Flowderived$24,295,653N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
Free Cash Flowderived$24,268,653N/M ended Sep 30, 2016 · filed Nov 3, 2016 · 34 d after period end